
October 1, 2026
UNC Health Advances Gene Therapy Research for Rett Syndrome
A clinical trial at UNC Hospitals offers new hope for children and families affected by the rare neurological disorder.

October 1, 2026
A clinical trial at UNC Hospitals offers new hope for children and families affected by the rare neurological disorder.

September 28, 2026
A new award is redesigning hospital care for people with Parkinson’s disease – a first of its kind, hospital to home care model that improves safety, mobility and recovery.

September 23, 2026
The study offers new insight into how genetic changes affect the structure of the human cortex, a brain region important for thinking and memory.

September 10, 2026
The innovation may help improve the fMRI experience for patients, while expanding opportunities for brain research.

July 7, 2026
UNC is the only medical institution in the world to use high frequency sound waves to inactivate brain tissue that causes epilepsy.

January 28, 2026
The clinical trial, led by James Howard Jr., MD., shows that a single course of six once-weekly infusions of Descartes-08 resulted in sustained clinically meaningful responses among patients with generalized myasthenia gravis.

January 2, 2026
The research, led by Nobel laureate and biochemist Aziz Sancar, MD, PhD, could revolutionize treatments for glioblastoma, an aggressive and deadly form of brain cancer.

November 5, 2025
UNC School of Medicine researchers led an international clinical trial of patients with generalized myasthenia gravis, finding the therapy is safe and effective across all subtypes.

October 27, 2025
A new clinic will bring ALS care to support the unique needs of individuals living in rural North Carolina.

August 20, 2025
Experts at the UNC School of Medicine and UNC Eshelman School of Pharmacy are focused on a pain drug candidate that can target an area of the brain that controls the ‘unpleasantness’ associated with pain.

July 7, 2025
The parents of twins Amelia and Makenzie Kahn, who have been battling Batten disease, a rare genetic disorder, for eight years, are now celebrating signs of progress one year into a first-in-kind clinical study at UNC Health. Led by Yael Shiloh-Malawsky, MD, the new personalized treatment, Zebronkysen, is helping to better manage the disease.

May 20, 2025
An analysis of Medicare data, led by researchers at the UNC School of Medicine, Duke University School of Medicine, and University of Texas Southwestern Medical Center, reveals that new dementia cases are falling but the number of people living with dementia is rising.